Comparative survival analysis of patients with HER2-low and HER2-positive metastatic breast cancer with or without brain metastases treated with trastuzumab deruxtecan
Publication Date
6-2-2024
Presented At:
American Society of Clinical Oncology (ASCO) Annual Meeting
Citation
Bardhan, Mainak; Hurmiz, Charlie; Ganiyani, Mohammad; Mahtani, Reshma; and Ahluwalia, Manmeet, "Comparative survival analysis of patients with HER2-low and HER2-positive metastatic breast cancer with or without brain metastases treated with trastuzumab deruxtecan" (2024). All Publications. 5478.
https://scholarlycommons.baptisthealth.net/se-all-publications/5478